The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review

Abstract Background The COVID-19 pandemic led to an unprecedented relaxation of restrictions on take-home doses in opioid agonist treatment (OAT). We conducted a mixed methods systematic review to explore the impact of these changes on program effectiveness and client experiences in OAT. Methods The...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Alison Adams, Sarin Blawatt, Tianna Magel, Scott MacDonald, Julie Lajeunesse, Scott Harrison, David Byres, Martin T. Schechter, Eugenia Oviedo-Joekes
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMC 2023-09-01
Rangatū:	Substance Abuse Treatment, Prevention, and Policy
Ngā marau:	Substance use Opioid use disorder Opioid agonist treatment COVID-19
Urunga tuihono:	https://doi.org/10.1186/s13011-023-00564-9
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!